Cefotiam
Gastric Varices
Shanghai Zhongshan HospitalSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Gastric Varices cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
D-PHENYLALANYL-L-CYSTEINYL-L-TYROSYL-D-TRYPTOPHYL-L-LYSYL-L-VALYL-L-CYSTEINYL-L-TRYPTOPHANAMIDE CYCLIC (2->7)-DISULFIDE Debiovision | Phase 3 | B |
Same molecule, other indications
Cefotiam is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →